Astellas Pharma Inc (OTCPK:ALPMF)
$ 11.095 -0.0325 (-0.29%) Market Cap: 19.93 Bil Enterprise Value: 24.15 Bil PE Ratio: 54.12 PB Ratio: 2.00 GF Score: 82/100

Astellas Pharma Inc Sustainability Briefing Transcript

Feb 28, 2022 / 06:00AM GMT
Release Date Price: $16.8
Kenji Yasukawa
Astellas Pharma Inc. - President, CEO & Representative Director

Good afternoon, everyone. I'm Yasukawa as a President of Astellas Pharma. Thank you for taking time out of your busy schedule to participate in our first sustainability meeting today. The Slide 2 is the caution statement. As usual, I would like to skip the reading out.

Page 3. First, I would like to explain about our vision. Today, there are some participants who are usually not participating in our meetings. There are many such participants. So first, I would like to talk about our vision, that is the upper concept in our corporate strategy, Japan OC -- excuse me, corporate strategic plan, or CSP. On the forefront of the health care change to turn innovative science into value for patients, that is our vision.

We have evolved and developed each strategy goals while inheriting the basic strategies in CSP2018 will contribute to the sustainability of society by solving social issues through its business activities by creating innovative pharmaceutical products. In addition, the trust that Astellas earns

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot